GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ADS Diagnostics Ltd (BOM:523031) » Definitions » Cyclically Adjusted Revenue per Share

ADS Diagnostics (BOM:523031) Cyclically Adjusted Revenue per Share : ₹61.61 (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is ADS Diagnostics Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

ADS Diagnostics's adjusted revenue per share for the three months ended in Mar. 2024 was ₹27.035. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹61.61 for the trailing ten years ended in Mar. 2024.

During the past 12 months, ADS Diagnostics's average Cyclically Adjusted Revenue Growth Rate was 13.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of ADS Diagnostics was 10.80% per year. The lowest was 10.80% per year. And the median was 10.80% per year.

As of today (2024-06-11), ADS Diagnostics's current stock price is ₹11.34. ADS Diagnostics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₹61.61. ADS Diagnostics's Cyclically Adjusted PS Ratio of today is 0.18.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ADS Diagnostics was 0.26. The lowest was 0.18. And the median was 0.22.


ADS Diagnostics Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for ADS Diagnostics's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ADS Diagnostics Cyclically Adjusted Revenue per Share Chart

ADS Diagnostics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 45.30 49.65 54.15 61.61

ADS Diagnostics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.29 54.15 58.46 60.79 61.61

Competitive Comparison of ADS Diagnostics's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, ADS Diagnostics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ADS Diagnostics's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ADS Diagnostics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where ADS Diagnostics's Cyclically Adjusted PS Ratio falls into.



ADS Diagnostics Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ADS Diagnostics's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=27.035/153.0345*153.0345
=27.035

Current CPI (Mar. 2024) = 153.0345.

ADS Diagnostics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 10.021 91.425 16.774
201406 6.949 94.103 11.301
201409 12.475 96.780 19.726
201412 5.320 96.780 8.412
201503 9.156 97.163 14.421
201506 12.668 99.841 19.417
201509 19.728 101.753 29.670
201512 7.549 102.901 11.227
201603 13.223 102.518 19.739
201606 15.358 105.961 22.181
201609 4.231 105.961 6.111
201612 3.209 105.196 4.668
201703 1.665 105.196 2.422
201706 11.433 107.109 16.335
201709 4.252 109.021 5.969
201712 2.916 109.404 4.079
201803 10.333 109.786 14.403
201806 5.497 111.317 7.557
201809 14.320 115.142 19.033
201812 6.723 115.142 8.936
201903 14.319 118.202 18.539
201906 18.964 120.880 24.009
201909 24.143 123.175 29.996
201912 6.694 126.235 8.115
202003 11.849 124.705 14.541
202006 6.076 127.000 7.322
202009 2.677 130.118 3.148
202012 17.132 130.889 20.031
202103 16.897 131.771 19.624
202106 6.636 134.084 7.574
202109 9.129 135.847 10.284
202112 19.278 138.161 21.353
202203 11.614 138.822 12.803
202206 9.118 142.347 9.803
202209 10.445 144.661 11.050
202212 16.792 145.763 17.630
202303 24.185 146.865 25.201
202309 32.953 151.492 33.289
202312 32.323 152.924 32.346
202403 27.035 153.035 27.035

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


ADS Diagnostics  (BOM:523031) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

ADS Diagnostics's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=11.34/61.61
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ADS Diagnostics was 0.26. The lowest was 0.18. And the median was 0.22.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


ADS Diagnostics Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of ADS Diagnostics's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


ADS Diagnostics (BOM:523031) Business Description

Traded in Other Exchanges
N/A
Address
114, Sant Nagar, East of Kailash, New Delhi, IND, 110065
ADS Diagnostics Ltd is an India based company engaged in the sale of medical equipment. It is focused on the business activity of the sale of trading goods, servicing and installation of medical equipment, lease rental, and distribution. The company generates key revenue from the sale of trading goods. It sells its products and services in India and internationally.

ADS Diagnostics (BOM:523031) Headlines

No Headlines